5Indexed trials
drug · Product Intelligence
Dimethyl Fumarate
Pipeline Intelligence
Dimethyl Fumarate: 5 indexed trials, 4 sponsors; 9 linked Orange Book patents and 10 FDA-linked events where matched.
4Sponsors
9Orange Book patent links
10FDA-linked events
Development evidence
NCT01838668Biogen · multiple_sclerosisPHASE3
NCT02675413Washington University School of Medicine · multiple_sclerosisPHASE4
NCT02746744Anders Svenningsson · multiple_sclerosisPHASE3
NCT06850597Medical University of Lodz · alzheimersPHASE2
NCT07483632Biogen · multiple_sclerosisPHASE3
FDA / patent evidence
11007167TECFIDERA · app 2040632035-11-16
11129806TECFIDERA · app 2040632035-11-16
11246850TECFIDERA · app 2040632035-11-16
10959972TECFIDERA · app 2040632035-11-16
11007166TECFIDERA · app 2040632035-11-16
10391160TECFIDERA · app 2040632035-03-13
10555993TECFIDERA · app 2040632035-03-13
10994003TECFIDERA · app 2040632035-03-13
8399514TECFIDERA · app 2040632028-02-07
Regulatory context
FDA_APPROVALDIMETHYL FUMARATE · 2025-01-06
FDA_APPROVALDIMETHYL FUMARATE · 2024-06-26
FDA_APPROVALDIMETHYL FUMARATE · 2022-12-22
FDA_APPROVALDIMETHYL FUMARATE · 2022-10-18
FDA_APPROVALDIMETHYL FUMARATE · 2021-03-26
FDA_APPROVALDIMETHYL FUMARATE · 2020-10-14
FDA_APPROVALDIMETHYL FUMARATE · 2020-09-24
FDA_APPROVALDIMETHYL FUMARATE · 2020-09-24
FDA_APPROVALDIMETHYL FUMARATE · 2020-09-24
FDA_APPROVALTECFIDERA · 2013-03-27
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.